Genome-wide characterisation of Hepatitis B mutations involved in clinical outcome

[1]  F. Balloux,et al.  A novel approach to characterise pathogen candidate genetic polymorphisms involved in clinical outcome. , 2006, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[2]  P. Simmonds,et al.  Recombination in the Genesis and Evolution of Hepatitis B Virus Genotypes , 2005, Journal of Virology.

[3]  F. Balloux,et al.  Geography is a better determinant of human genetic differentiation than ethnicity , 2005, Human Genetics.

[4]  M. Kew,et al.  Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy , 2005, Journal of viral hepatitis.

[5]  K. C. Lee,et al.  Mutation analysis of hepatitis B virus promoters in chronically infected children , 2005, Archives of Virology.

[6]  S. Schaefer.  Hepatitis B virus: significance of genotypes , 2005, Journal of viral hepatitis.

[7]  S. Urban,et al.  Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein , 2004, Journal of Virology.

[8]  R. Gish,et al.  HBV core sequence: definition of genotype‐specific variability and correlation with geographical origin , 2004, Journal of viral hepatitis.

[9]  Michael P. Cummings,et al.  PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .

[10]  A. Lok,et al.  Hepatitis B virus genotypes: Do they play a role in the outcome of HBV infection? , 2004, Hepatology.

[11]  Sudhir Kumar,et al.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment , 2004, Briefings Bioinform..

[12]  Christina Gloeckner,et al.  Modern Applied Statistics With S , 2003 .

[13]  C. Howard.  Hepatitis viruses: A Pandora's box? , 2002, Journal of gastroenterology and hepatology.

[14]  C. Freitag,et al.  Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins , 2002, The Lancet.

[15]  P. Karayiannis,et al.  Detection and significance of a G1862T variant of hepatitis B virus in Chinese patients with fulminant hepatitis. , 2002, The Journal of general virology.

[16]  J. Torresi.  The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  J. Kao.  Hepatitis B viral genotypes: Clinical relevance and molecular characteristics , 2002, Journal of gastroenterology and hepatology.

[18]  A. Kidd,et al.  Genetic variability in hepatitis B viruses. , 2002, The Journal of general virology.

[19]  Ding‐Shinn Chen,et al.  Genotypes and Clinical Phenotypes of Hepatitis B Virus in Patients with Chronic Hepatitis B Virus Infection , 2002, Journal of Clinical Microbiology.

[20]  D. Jackson,et al.  Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. , 2002, Virology.

[21]  D. Swofford.  PAUP*: Phylogenetic analysis using parsimony (*and other methods), Version 4.0b10 , 2002 .

[22]  E. Holmes,et al.  A Revised Evolutionary History of Hepatitis B Virus (HBV) , 2002, Journal of Molecular Evolution.

[23]  H. Whittle,et al.  Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers , 2001, Journal of medical virology.

[24]  M. Thursz.  Genetic susceptibility in chronic viral hepatitis. , 2001, Antiviral research.

[25]  S. Locarnini,et al.  Hepatitis B virus mutants and fulminant hepatitis B: Fitness plus phenotype , 2001, Hepatology.

[26]  Y. Wen,et al.  Full‐length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma , 2001, Journal of medical virology.

[27]  Günther.  Naturally occurring mutations of hepatitis B virus and outcome of chronic infection: Is there an association? , 2000, European journal of clinical investigation.

[28]  W. Jilg,et al.  High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. , 2000, The Journal of general virology.

[29]  E. Hildt,et al.  Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens , 2000, Gene Therapy.

[30]  Ding‐Shinn Chen,et al.  Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. , 2000, Gastroenterology.

[31]  K. Kidd‐Ljunggren,et al.  Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti‐HBe , 2000, Journal of medical virology.

[32]  C. Hannoun,et al.  Long-term mutation rates in the hepatitis B virus genome. , 2000, The Journal of general virology.

[33]  S. Günther,et al.  Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions. , 1999, The Journal of general virology.

[34]  C. Mayerat,et al.  Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? , 1999, Journal of viral hepatitis.

[35]  H. Rho,et al.  Interaction of Hepatitis B Viral X Protein and CCAAT/ Enhancer-binding Protein α Synergistically Activates the Hepatitis B Viral Enhancer II/Pregenomic Promoter* , 1999, The Journal of Biological Chemistry.

[36]  C. Spangenberg,et al.  Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity. , 1998, Journal of medical virology.

[37]  K. Chayama,et al.  Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen–positive asymptomatic healthy carriers , 1998, Journal of medical virology.

[38]  M. Burgess,et al.  Molecular epidemiology and variation of hepatitis B in recent immigrant families to Australia , 1998, Journal of medical virology.

[39]  Torre,et al.  Clinical implications of mutations in the hepatitis B virus genome , 1998, European journal of clinical investigation.

[40]  K. Chayama,et al.  Emergence and takeover of YMDD motif mutant hepatitis B virus during long‐term lamivudine therapy and re‐takeover by wild type after cessation of therapy , 1998, Hepatology.

[41]  S. Günther,et al.  Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. , 1998, Virology.

[42]  W. Carman,et al.  The clinical significance of surface antigen variants of hepatitis B virus , 1997, Journal of viral hepatitis.

[43]  C. Cunningham,et al.  Can three incongruence tests predict when data should be combined? , 1997, Molecular biology and evolution.

[44]  G. Fattovich,et al.  Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission. , 1997, The Journal of infectious diseases.

[45]  W. Edmunds,et al.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr , 1996, Epidemiology and Infection.

[46]  A. Dhillon,et al.  Hepatitis B virus carriers without precore mutations in hepatitis B e antigen‐negative stage show more severe liver damage , 1996, Hepatology.

[47]  T. Yen,et al.  Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles , 1996, Journal of virology.

[48]  B. Moss,et al.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis , 1995, The Journal of experimental medicine.

[49]  K. Hasegawa,et al.  Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis , 1994, Journal of virology.

[50]  D. Krüger,et al.  Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus. , 1994, Intervirology.

[51]  A J Hall,et al.  The influence of age on the development of the hepatitis B carrier state , 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[52]  A. Raney,et al.  Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor , 1992, Journal of virology.

[53]  A. Bertoletti,et al.  Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. , 1992, Gastroenterology.

[54]  F. Chisari,et al.  Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. , 1991, The Journal of clinical investigation.

[55]  D. Ganem,et al.  Epitope mapping of the PreS1 domain of the hepatitis B virus large surface protein. , 1990, Virology.

[56]  P. Hofschneider,et al.  The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator , 1990, Nature.

[57]  H. Thomas,et al.  MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.

[58]  M. Sobsey,et al.  Replication kinetics and cytopathic effect of hepatitis A virus. , 1989, The Journal of general virology.

[59]  M. M. Wu,et al.  Hepatitis B virus markers in Chinese twins. , 1989, Anticancer research.

[60]  Y. Shaul,et al.  High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter. , 1986, The EMBO journal.

[61]  B. Schwartz.  Letter: Ondine's curse. , 1976, Lancet.